Loading...
Pathological transition as the arising mechanism for drug resistance in lung cancer
Despite the tremendous efforts for improving therapeutics of lung cancer patients, its prognosis remains disappointing. This can be largely attributed to the lack of comprehensive understanding of drug resistance leading to insufficient development of effective therapeutics in clinic. Based on the c...
Na minha lista:
| Udgivet i: | Cancer Commun (Lond) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6771104/ https://ncbi.nlm.nih.gov/pubmed/31570104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-019-0402-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|